Market Research Logo

GC Pharma (006280) - Financial and Strategic SWOT Analysis Review

GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and antithrombin; vaccines for infectious diseases; prescription drugs for treating cardiovascular, respiratory, central nervous system (CNS), gastrointestinal and immunology diseases, musculoskeletal disorders, genetic disorders, metabolic disorders and hematological disorders; and Over-the-counter (OTC) drugs including anti-inflammatory drugs, anti-allergic products and others. The company focuses its research and development activities at developing pharmaceuticals for difficult to treat diseases, including cancer. GC Pharma is headquartered Yongin-si, Gyeonggi-do, South Korea.

GC Pharma Key Recent Developments

Jul 31,2018: GC Pharma Reports Q2 2018 Results
Jul 03,2018: Platform technologies key to developing new drugs
May 20,2018: GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines
Apr 27,2018: GC Pharma Announces Q1 2018 Results
Mar 08,2018: GC Pharma gets Korean approval for Lantus biosimilar

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
GC Pharma - Key Facts
GC Pharma - Key Employees
GC Pharma - Key Employee Biographies
GC Pharma - Major Products and Services
GC Pharma - History
GC Pharma - Company Statement
GC Pharma - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
GC Pharma - Business Description
Business Segment: Eliminations
Performance
Business Segment: Green Cross Corp
Overview
Performance
Business Segment: Green Cross Genome Co Ltd
Overview
Performance
Business Segment: Green Cross LabCell Co Ltd
Overview
Performance
Business Segment: Green Cross Medical Science Co Ltd
Overview
Performance
Business Segment: Green Cross Medis Corp
Overview
Performance
Business Segment: Green Cross Wellbeing Co Ltd
Overview
Performance
Business Segment: Invac Pharm Corp
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Overseas
Performance
R&D Overview
GC Pharma - Corporate Strategy
GC Pharma - SWOT Analysis
SWOT Analysis - Overview
GC Pharma - Strengths
GC Pharma - Weaknesses
GC Pharma - Opportunities
GC Pharma - Threats
GC Pharma - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
GC Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
GC Pharma, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 31, 2018: GC Pharma Reports Q2 2018 Results
Jul 31, 2018: GC Pharma Reports Q2 2018 Results
Jul 31, 2018: GC Pharma Reports Q2 2018 Results
May 20, 2018: GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines
Feb 05, 2018: GC Pharma Reports Full Year 2017 Results
Apr 29, 2017: Green Cross to Build Cell Therapy Manufacturing Facility in China
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
GC Pharma, Key Facts
GC Pharma, Key Employees
GC Pharma, Key Employee Biographies
GC Pharma, Major Products and Services
GC Pharma, History
GC Pharma, Other Locations
GC Pharma, Subsidiaries
GC Pharma, Key Competitors
GC Pharma, Ratios based on current share price
GC Pharma, Annual Ratios
GC Pharma, Annual Ratios (Cont...1)
GC Pharma, Annual Ratios (Cont...2)
GC Pharma, Interim Ratios
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
GC Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
GC Pharma, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
GC Pharma, Performance Chart (2013 - 2017)
GC Pharma, Ratio Charts
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
GC Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report